改善了与HPV相关的鼻腔状细胞癌的存活率,并进行了化疗辐射治疗
Jamie R Oliver1, Naomi C Wang1, Rahul Alapati1
1Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, Kansas, USA.
Head & neck
|January 8, 2026
概括
人类乳头瘤病毒阳性 (HPV+) 鼻状状细胞癌 (SNSCC) 显示化学辐射的生存率有所改善. HPV 检测可以为 HPV+ SNSCC 患者提供量身定制的治疗指导.
科学领域:
- 在瘤学瘤学.
- 头部和部癌症 头部和部癌症
- 人类乳头瘤病毒 (HPV) 研究研究
背景情况:
- 人类乳头瘤病毒相关的 (HPV+) 鼻腔状细胞癌 (SNSCC) 显示出比HPV阴性SNSCC更好的整体存活率 (OS).
- 关于HPV+SNSCC治疗特定结果的数据有限.
研究的目的:
- 调查HPV状况与鼻状状细胞癌 (SNSCC) 治疗结果之间的关联.
- 为了确定HPV阳性是否与特定的治疗方式提供生存益处.
主要方法:
- 分析国家癌症数据库 (NCDB) 对2010年至2017年间通过HPV检测诊断的SNSCC病例的分析.
- 多变量考克斯回归用于确定预后变量.
- 创建倾向分数匹配的队列,在各种治疗策略中比较HPV阳性和HPV阴性患者.
主要成果:
- 总共有1697例HPV测试的SNSCC病例被确定;32.5%是HPV+.
- HPV 状态,年龄,并发症评分,瘤大小,淋巴血管侵入,阶段和外科边缘状态是显著的预后因素.
- 在接受化学辐射治疗 (HR=0.55;p=0.01) 的患者中,HPV阳性与改善的5年生存率显著相关,但不仅仅是手术,手术与辐射或仅仅是辐射.
结论:
- HPV+SNSCC似乎对化疗辐射特别敏感,这表明潜在的生存益处.
- 建议进行常规HPV测试,以确定可能受益于基于化学辐射的量身定制治疗方法的患者.
- 对SNSCC的HPV特定治疗策略进行进一步的研究是有必要的.
相关概念视频
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:21Cancer Survival Analysis
639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639